EMVision Medical Devices Ltd Stock

Equities

EMV

AU0000028375

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. 01:58:09 2024-04-24 am EDT 5-day change 1st Jan Change
2.2 AUD -2.65% Intraday chart for EMVision Medical Devices Ltd -3.51% +29.79%
Sales 2022 4.36M 2.84M Sales 2023 6.97M 4.55M Capitalization 91.16M 59.42M
Net income 2022 -6M -3.91M Net income 2023 -3M -1.96M EV / Sales 2022 25.3 x
Net cash position 2022 6.06M 3.95M Net cash position 2023 6.93M 4.52M EV / Sales 2023 12.1 x
P/E ratio 2022
-18.5 x
P/E ratio 2023
-23.5 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 66.25%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.65%
1 week-3.51%
Current month-14.40%
1 month-14.40%
3 months+6.28%
6 months+33.74%
Current year+29.79%
More quotes
1 week
2.19
Extreme 2.19
2.29
1 month
2.17
Extreme 2.17
2.68
Current year
1.75
Extreme 1.75
2.72
1 year
1.13
Extreme 1.13
2.72
3 years
1.13
Extreme 1.13
3.42
5 years
0.36
Extreme 0.36
4.20
10 years
0.28
Extreme 0.28
4.20
More quotes
Managers TitleAgeSince
Chief Executive Officer - -
Chief Tech/Sci/R&D Officer - 19-12-31
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 78 20-09-28
Director/Board Member - 18-03-31
Director/Board Member - 18-06-30
More insiders
Date Price Change Volume
24-04-24 2.2 -2.65% 59,916
24-04-23 2.26 +0.89% 39,644
24-04-22 2.24 +0.90% 51,698
24-04-19 2.22 -3.48% 71,076
24-04-18 2.3 +0.88% 26,208

Delayed Quote Australian S.E., April 24, 2024 at 01:58 am EDT

More quotes
EMVision Medical Devices Limited is an Australia-based medical device company developing an approach to looking inside the human body. The Company is engaged in the research and development of medical imaging and diagnostic technology (the EMVision Technology), for the purpose of commercializing a portable medical device for stroke diagnosis and monitoring as well as other medical imaging needs. The Company is developing and commercializing medical imaging diagnostics for various disease states and medical emergencies. The Company’s product pipeline includes portable, non-invasive, neuroimaging devices. Its lead product in development includes a portable, non-ionizing brain scanner, capable of producing images of biological tissue to provide insights for clinicians. Its second-generation device is an ultra-light weight device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients regardless of location.
More about the company

Annual profits - Rate of surprise